bpc 157 safety research BPC-157 for athletes and injury treatment: Science, safety, and legal concerns Before You Try BPC-157, Watch

Schraga is a concierge physician at CrescendoMD in the San Francisco Bay Area who focuses on prevention, longevity, and personalized primary care

GHK-Cu is found endogenously in human plasma, saliva, and urine, with plasma concentrations declining from approximately 200 ng/mL at age 20 to 80 ng/mL by age 60

Route/evidence mismatch: the pivotal mouse study tested subcutaneous injection at a fixed research dose (20 mg/kg, three times daily) the oral capsule use that is actually sold and discussed commercially has not itself been directly tested in that published research

As BPC-157 is considered a research peptide, it is important to understand that its use is not within the scope of FDA approval

By targeting inflammation and helping the body repair itself, peptide therapy provides long-lasting relief without the risks of surgery or heavy medications